These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10694694)

  • 1. Maternal age-specific rates of Down syndrome used in serum screening are biased low.
    Hook EB
    Prenat Diagn; 2000 Feb; 20(2):169. PubMed ID: 10694694
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of bias in MoM values on patient risk and screening performance for Down syndrome.
    Nix B; Wright D; Baker A
    Prenat Diagn; 2007 Sep; 27(9):840-5. PubMed ID: 17600858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003.
    Van Dyke DL; Ebrahim SA; Al Saadi AA; Powell SA; Zenger-Hain JL; Micale MA; Wiktor AE; Zou YS
    Prenat Diagn; 2007 Jun; 27(6):583-4. PubMed ID: 17546696
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome.
    Alberman E; Huttly W; Hennessy E; McIntosh A
    Prenat Diagn; 2003 Oct; 23(10):801-6. PubMed ID: 14558023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Tell them it's not so bad": prenatal screening for down syndrome and the bias toward abortion.
    Bauer PE
    Intellect Dev Disabil; 2008 Jun; 46(3):247-51. PubMed ID: 18578584
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and false-positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages.
    Muller F; Thalabard JC; Ngo S; Dommergues M
    Prenat Diagn; 2002 May; 22(5):350-3. PubMed ID: 12001184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for Down syndrome in the older woman: a risky business?
    Hodges RJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):486-8. PubMed ID: 16401213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester screening for Down syndrome in multiple pregnancy.
    Cleary-Goldman J; Berkowitz RL
    Semin Perinatol; 2005 Dec; 29(6):395-400. PubMed ID: 16533653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antenatal screening for Down syndrome: a smattering of epidemiology].
    Boulvain M; Billieux MH; Irion O
    Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of Down syndrome and prenatal diagnosis during the years 1984-88 in Finland].
    Salonen R; Simola KO; Harjulehto-Mervaala T; Aro T; Saxén L
    Duodecim; 1993; 109(8):681-6. PubMed ID: 8062742
    [No Abstract]   [Full Text] [Related]  

  • 16. Down syndrome: current stage of cytogenetic epidemiology.
    Mikkelsen M
    Prog Clin Biol Res; 1982; 103 Pt B():297-309. PubMed ID: 6219400
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy.
    Abdul-Hamid S; Fox R; Martin I
    J Obstet Gynaecol; 2004 Jun; 24(4):374-6. PubMed ID: 15203574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-standardisation when target setting and auditing performance of Down syndrome screening programmes.
    Cuckle H; Aitken D; Goodburn S; Senior B; Spencer K; Standing S;
    Prenat Diagn; 2004 Nov; 24(11):851-6. PubMed ID: 15565561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.